BRCA mutation testing in determining breast cancer therapy

KL Smith, C Isaacs - The Cancer Journal, 2011 - journals.lww.com
BRCA mutation–associated breast cancer differs from sporadic breast cancer with regard to
future cancer risks and sensitivity to systemic therapies. Now that rapid genetic testing for …
被引用次数：112 相关文章

BRCA mutation testing in determining breast cancer therapy

KL Smith, C Isaacs - Cancer Journal, 2011 - pure.johnshopkins.edu
BRCA mutation-associated breast cancer differs from sporadic breast cancer with regard to
future cancer risks and sensitivity to systemic therapies. Now that rapid genetic testing for …

BRCA mutation testing in determining breast cancer therapy

KL Smith, C Isaacs - Cancer journal (Sudbury, Mass.), 2011 - pubmed.ncbi.nlm.nih.gov
BRCA mutation-associated breast cancer differs from sporadic breast cancer with regard to
future cancer risks and sensitivity to systemic therapies. Now that rapid genetic testing for …

BRCA mutation testing in determining breast cancer therapy.

KL Smith, C Isaacs - Cancer Journal (Sudbury, Mass.), 2011 - europepmc.org
BRCA-mutation associated breast cancer differs from sporadic breast cancer with regard to
future cancer risks and sensitivity to systemic therapies. Now that rapid genetic testing for …
[HTML] nih.gov

[HTML][HTML] BRCA Mutation Testing in Determining Breast Cancer Therapy

KL Smith, C Isaacs - Cancer journal (Sudbury, Mass.), 2011 - ncbi.nlm.nih.gov
BRCA-mutation associated breast cancer differs from sporadic breast cancer with regard to
future cancer risks and sensitivity to systemic therapies. Now that rapid genetic testing for …

BRCA mutation testing in determining breast cancer therapy.

KL Smith, C Isaacs - Cancer Journal (Sudbury, Mass.), 2011 - europepmc.org
BRCA-mutation associated breast cancer differs from sporadic breast cancer with regard to
future cancer risks and sensitivity to systemic therapies. Now that rapid genetic testing for …